These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12888186)

  • 1. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu CC; Shen WW
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):267-71. PubMed ID: 12888186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
    J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
    Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
    BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
    Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
    Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
    Nemets H; Nemets B; Apter A; Bracha Z; Belmaker RH
    Am J Psychiatry; 2006 Jun; 163(6):1098-100. PubMed ID: 16741212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial.
    Freeman MP; Hibbeln JR; Silver M; Hirschberg AM; Wang B; Yule AM; Petrillo LF; Pascuillo E; Economou NI; Joffe H; Cohen LS
    Menopause; 2011 Mar; 18(3):279-84. PubMed ID: 21037490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
    Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
    J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
    Rice SM; Hickie IB; Yung AR; Mackinnon A; Berk M; Davey C; Hermens DF; Hetrick SE; Parker AG; Schäfer MR; McGorry PD; Amminger GP
    Early Interv Psychiatry; 2016 Aug; 10(4):290-9. PubMed ID: 25130262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
    Stoll AL; Severus WE; Freeman MP; Rueter S; Zboyan HA; Diamond E; Cress KK; Marangell LB
    Arch Gen Psychiatry; 1999 May; 56(5):407-12. PubMed ID: 10232294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.
    Mazereeuw G; Herrmann N; Oh PI; Ma DW; Wang CT; Kiss A; Lanctôt KL
    J Clin Psychopharmacol; 2016 Oct; 36(5):436-44. PubMed ID: 27529771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
    Lin PY; Su KP
    J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
    Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
    J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
    Liu JJ; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
    J Clin Psychiatry; 2013 Jul; 74(7):732-8. PubMed ID: 23945451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study.
    Freeman MP; Davis M; Sinha P; Wisner KL; Hibbeln JR; Gelenberg AJ
    J Affect Disord; 2008 Sep; 110(1-2):142-8. PubMed ID: 18206247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.